Back to search

Aristotle University Of Thessaloniki (AUTH)

Ανθεκτικότητα των μυκήτων που αποικίζουν το γαστρεντερικό σωλήνα παιδιών με ειδικές παθήσεις (κακοήθη νοσήματα, νοσηλεία σε ΜΕΘ)

Abstract

dc:description

Invasive fungal infections constitute a threat for immunocompromised pediatric patients. Fungal colonization of gastrointestinal tract is considered to be the first step of invasive infection. This study was undertaken to evaluate colonization density and antifungal susceptibility on yeasts colonizing GI tract of patients hospitalized in Pediatric Intensive Care Unit (PICU) and Pediatric Oncology Department (POD) of Hippokration Hospital in Thessaloniki, Greece. Colonization density was evaluated by studying 314 and 127 patients admitted in PICU and POD between 2000-2003 and 2001-2004 respectively. Oropharyngeal and rectal specimens were taken from all patients, whereas gastric acid was only collected from PICU patients. Specimens were cultured and colonization density was assessed semi-quantitatively. Yeasts were classified as C. albicans and non-albicans Candida spp. by germ tube formation test. Susceptibility was only tested on strains isolated from 23 of 314 PICU and 21 of 127 POD patients enrolled in the protocol. Protocol inclusion criterion was fungal GI tract colonization for at least 2 weeks and absence of topical or systemic fungal infection at the time of specimen collection. Epidemiological details, drugs and therapeutic interventions were recorded on 44 protocol patients and non-albicans Candida spp. isolated were identified by API ID 32C test. Antifungal susceptibility was determined by CLSI (NCCLS) Μ27-A2 micromethod. Minimum inhibitory concentrations (MIC) and minimum fungicidal concentrations (MFC) of amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole, posaconazole and caspofungin were evaluated. Almost half (45%) of PICU children and 28% of POD children were already colonized on admission. Candida albicans was isolated from 56% and 82% of colonized children in PICU and POD respectively. Colonization density increased in 26% of PICU patients and 11% of POD patients hospitalized more than 1 week. Furthermore, 50% and 32% of not initially colonized patients were finally colonized by fungi in both departments. PICU environment predisposed to non-albicans Candida spp. colonization, as well as to mixed colonization. Colonization density changes were mainly taken place in less than 14 days. All isolates were extremely susceptible to AMB and 94-97% of them were susceptible to flucytosine. Old triazoles fluconazole and itraconazole exhibited potent activity in 97-100% of C. albicans and 88-91% of non-albicans Candida spp.. Voriconazole and posaconazole exhibited potent activity in 98-100% of all strains tested. Cross-resistance was detected in all azoles studied. Caspofungin exhibited potent activity against all C.albicans and against 72-94% of non-albicans Candida spp. tested. Interestingly, caspofungin was very active against resistant to azoles isolates. Amphotericin B and caspofungin exhibited potent fungicidal activity, whereas flucytosine exhibited moderate activity and azoles had to be used in high concentrations in order to be fungicidal. It is of note, that azoles demonstrated less potent fungicidal activity in PICU than in POD. Antifungal susceptibility pattern remained stable for amphotericin B, caspofungin and flucytosine during hospitalization time. On the other hand, in PICU, final isolates had higher MICs or/and MFCs than initial ones to all azoles tested. Differences were significant for MIC and MFC to voriconazole (p=0.04 and p=0.03 respectively). Furthermore, final isolates tented to have higher MIC to itraconazole (p=0.06) and higher MFC values to itraconazole (p=0.06), fluconazole (p=0.06) and posaconazole (p=0.06) than the initial isolates. Susceptibility changes took place in a median time of 21 days (14 - 120). In POD, azoles exhibited unchanged activity, apart from posaconazole that its inhibitory activity expressed with MIC100 and fungicidal activity increased (p=0.01 and p=0.06). MIC100 and MFC values seem better prognostic factors of resistance to azoles than MIC80 values. At the end of study period, 20% of protocol patients were colonized with less susceptible isolates and 20% of them were colonized with more susceptible ones than on admission. Drugs affected mostly were azoles and flucytosine. In PICU patients colonization with less susceptible isolates was related to parenteral nutrition >14 days (p=0.04). On the contrary, colonizaiton with more susceptible isolates was related to rhinogastric use < 14 days (p=0.04) and lack of cephalosporins intravenously (p=0.04). There was a tendency of more susceptible strains to be found in patients who had been given corticosteroids < 7 days (p=0.09), aminoglycosides < 14 days (p=0.08) and H₂ inhibitors < 14 days (p=0.08). In conclusion, colonization density and antifungal susceptibility pattern of fungi colonizing GI tract of PICU and POD patients changed significantly during study period. PICU environment predispose to colonization with Candida spp., especially with non-albicans Candida spp. All drugs studied exhibited potent activity against the majority of Candida spp. tested.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2007

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Filioti, Joanna
  • Φιλιώτη, Ιωάννα

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/19585

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Filioti, Joanna; Φιλιώτη, Ιωάννα. Ανθεκτικότητα των μυκήτων που αποικίζουν το γαστρεντερικό σωλήνα παιδιών με ειδικές παθήσεις (κακοήθη νοσήματα, νοσηλεία σε ΜΕΘ). Aristotle University Of Thessaloniki (AUTH), 2007. http://hdl.handle.net/10442/hedi/19585